Track record · closed signal

Hims & Hers Health, Inc. (HIMS) — closed signal from January 7, 2026

Partial Published before the outcome was known, scored automatically when the window closed on April 7, 2026.

Predicted vs. what happened

HIMS price · publication thesis → realized outcomesplit-adjusted

$33.00 – $36.00Entry zone — fair-value band

$36.14Published — price the day we called it

$42.64Target — the price the thesis aimed for

$36.45Peak — highest point inside the window, not a realized return

$20.33Window close — end-of-window price, context only

What happened

Partial

Reached 5% of the predicted growth at its peak, without hitting the target.

Peak price

$36.45

peak on January 7, 2026 — not a realized return

Peak gain

+0.9%

peak, from the publication price

Window close

$20.33

end-of-window price, context only

Days to target

—

Window

January 7, 2026 – April 7, 2026

The thesis — published January 7, 2026

Predicted growth

+18%

over the measurement window

Target price

$42.64

the price the thesis aimed for

Entry zone

$33.00 – $36.00

the fair-value band we waited for

Price at publication

$36.14

published January 7, 2026

Confidence

63%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

This is a short-term trade that can move quickly. Lots of traders are betting against the stock, and some analysts say the shares may be cheaper than they should be. That mix can cause sudden squeezes up or fast drops. After a recent strong move, a safer approach is to wait for a pullback and only buy if the price stabilizes and rises calmly.

Primary drivers

Many traders betting against it can force fast upside moves
Notes that shares look cheap can attract bargain buyers
Recurring subscriptions give predictable short-term revenue
Recent strong gains increase chance of a near-term pullback

How it played out

HIMS: the target was not reached

Lyra published HIMS at $36.14 on January 7, 2026, with an expected gain of 18%. The thesis pointed to heavy short interest, comments that the shares looked cheap, recurring subscriptions, and the risk that recent strong gains could lead to a near-term pullback.

Inside the January 7 to April 7 window, HIMS peaked at $36.45 on January 7, a gain of 0.9%. It stayed below the $42.64 target and never reached it. By the end of the window, the stock was $20.33. The thesis missed.

What happened during the window

On February 19, 2026, Hims & Hers announced an agreement to acquire Eucalyptus, an international digital health company. The announcement said Eucalyptus operated in Australia, the UK, Germany, Japan, and Canada.

Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All HIMS signals